6 clinically reviewed articles, written and peer-reviewed by the HealthRX.com Medical Team.
Showing 6 of 6 clinical reviews.
A clinical deep-dive into vaginal estradiol pharmacogenomics, ethnicity-stratified trial data, and practical dose-adjustment considerations for Black and African ancestry patients, reviewed by the HealthRX.com medical team.
A clinician-reviewed guide to how CYP2C19/CYP2D6 pharmacogenomics, lower BMI thresholds, and ethnicity-stratified trial data affect vaginal estradiol dosing and safety in East Asian patients.
Evidence-based review of vaginal estradiol efficacy differences in East Asian women, including CYP enzyme polymorphisms, BMI-adjusted dosing, and population-specific pharmacogenomic data.
Evidence-based review of vaginal estradiol safety considerations for Hispanic and Latino women, including pharmacogenomic variation, metabolic comorbidities, and clinical monitoring guidance.
Evidence review of vaginal estradiol efficacy in South Asian patients, covering pharmacogenomic variations, dosing considerations, and documented gaps in ethnicity-stratified trial data.
South Asian women may need tailored vaginal estradiol dosing due to pharmacogenomic differences, earlier menopause onset, and cardiovascular risk at lower BMI. This HealthRX.com guide covers ethnicity-specific dose adjustment evidence, CYP19A1 variants, and clinical decision frameworks.